NAFPENZAL DC
NAFPENZAL DC
Authorised
- Dihydrostreptomycin sulfate
- Nafcillin
- Benzylpenicillin procaine
Product identification
Medicine name:
НАФПЕНЗАЛ ДЦ
NAFPENZAL DC
Active substance:
- Dihydrostreptomycin sulfate
- Nafcillin
- Benzylpenicillin procaine
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Dihydrostreptomycin sulfate100.00milligram(s)1.00Syringe
-
Nafcillin100.00milligram(s)1.00Syringe
-
Benzylpenicillin procaine300.00milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle
-
Meat and offal14dayМляко:При интервал между лечението и отелването повече от 42 дни: 3 издоявания след отелването
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51R
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-1632
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 11/04/2022
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 11/04/2022
How useful was this page?: